Superfund Research Program

Meghan E. Rebuli

University of North Carolina-Chapel Hill
4310 Mary Ellen Jones
116 Manning Drive
CB#7325
Chapel Hill, North Carolina 27599-7142
Phone: 919-966-6898
Email: meradfor@email.unc.edu

Projects

• University of North Carolina-Chapel Hill: Research Experience and Training Coordination Core (RETCC) (2020-2025)

Publications

• Silveyra P, Al Houssein H, Rebuli ME. Sex and Gender Differences In The Susceptibility to Environmental Exposures. Chapter 9 in: Sex-Based Differences in Lung Physiology. Springer, (accepted for publication)

2023

• Payton A, Roell K, Rebuli ME, Valdar W, Rager JE. 2023. Navigating the bridge between wet and dry lab toxicology research to address current challenges with high-dimensional data. Front Toxicol 5:1171175. doi:10.3389/ftox.2023.1171175 PMID:37304253 PMCID:PMC10250703

2022

• Hickman E, Payton A, Duffney PF, Wells H, Ceppe AS, Brocke SA, Bailey A, Rebuli ME, Robinette C, Ring B, Rager JE, Alexis N, Jaspers I. 2022. Biomarkers of airway immune homeostasis differ significantly with generation of e-cigarettes. Am J Respir Crit Care Med 206(10):1248-1258. doi:10.1164/rccm.202202-0373OC PMID:35731626 PMCID:9746848
• Hsiao Y, Liu C, Robinette C, Knight N, Lu K, Rebuli ME. 2022. Development of LC-HRMS untargeted analysis methods for nasal epithelial lining fluid exposomics. J Expo Sci Environ Epidemiol doi:10.1038/s41370-022-00448-3
• Islam T, Braymiller J, Eckel SP, Tackett AP, Rebuli ME, Barrington-Trimis J, McConnell R. 2022. Secondhand nicotine vaping at home and respiratory symptoms in young adults. Thorax doi:10.1136/thoraxjnl-2021-217041 PMID:35013000
• Payton A, Perryman AN, Hoffman JR, Avula V, Wells H, Robinette C, Alexis N, Jaspers I, Rager JE, Rebuli ME. 2022. Cytokine signature clusters as a tool to compare changes associated with tobacco product use in upper and lower airway samples. Am J Physiol Lung Cell Mol Physiol 322(5):L722-L736. doi:10.1152/ajplung.00299.2021 PMID:35318855 PMCID:PMC9054348
• Tackett A, Rebuli ME. 2022. Alternative Flavored Inhalable Products-A New Respiratory Hazard?. Toxicol Sci 187(1):1-2. doi:10.1093/toxsci/kfac021 PMID:35472170 PMCID:PMC9041544

2021

• Escobar YH, Morrison CB, Chen Y, Hickman E, Love CA, Rebuli ME, Surratt JD, Ehre C, Jaspers I. 2021. Differential responses to e-cig generated aerosols from humectants and different forms of nicotine in epithelial cells from non-smokers and smokers. Am J Physiol Lung Cell Mol Physiol 320:L1064-L1073. doi:10.1152/ajplung.00525.2020 PMID:33825493 PMCID:PMC8285624
• Rebuli ME, Brocke SA, Jaspers I. 2021. Impact of inhaled pollutants on response to viral infection in controlled exposures. Journal of Allergy and Clinical Immunology 148(6):doi:10.1016/j.jaci.2021.07.002 PMID:34252446 (ahead of print)
• Rebuli ME, Glista-Baker E, Hoffman JR, Duffney PF, Robinette C, Speen AM, Pawlak EA, Dhingra R, Noah TL, Jaspers I. 2021. Electronic-cigarette use alters nasal mucosal immune response to live-attenuated influenza virus: A clinical trial. Am J Respir Cell Mol Biol 64(1):126-137. doi:10.1165/rcmb.2020-0164OC PMID:33095645 PMCID:PMC7781000

2020

• Rebuli ME. 2020. Why males may have a worse response to COVID-19. (non-peer reviewed)

2016

• Martin EM, Clapp PW, Rebuli ME, Pawlak EA, Glista-Baker E, Benowitz NL, Fry RC, Jaspers I. 2016. E-cigarette use results in suppression of immune and inflammatory-response genes in nasal epithelial cells similar to cigarette smoke. Am J Physiol 311(1):L135-L144. doi:10.1152/ajplung.00170.2016 PMID:27288488 PMCID:PMC4967187